The November Innovation in Action newsletter is available, you can view it here.
To subscribe to future editions simply …
The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank
The AbVance project aims to accelerate biologics drug discovery by increasing knowledge of antibody structures in the public domain
Nearly 200 participants attended our 2017 Annual USA Conference, a record attendance which helped provide us with a great platform …
Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
By Mark Manfredi, Project Lead and IT Business Process Analyst at Bristol-Meyers Squibb
Bristol-Myers Squibb has found substantial value …
* A full list of our membership including individual members can be found here. (Last updated May 18 2018)
- President's Startup Challenge 2018 - Open for entries
09 Jul 2018 - 03 Sep 2018,
- Applying NGS Technologies in Precision Medicine
10 Sep 2018, London
- Pistoia Alliance Debates. Webinar - So that's what a blockchain is! An in-depth introduction
18 Sep 2018,